Loading company…
Wuhan Changlian Laifu Pharmaceutical develops and manufactures pharmaceutical products for health needs in China.
Founded in 2004 and headquartered in Wuhan, China, the company develops and manufactures medications for common health issues, distributed through various channels. In July 2011 it received CNY 60 million from JD Capital. Its 2021 revenue was CNY 19,323,360.1, with an EBITDA of CNY 654,160.9.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Wuhan Changlian Laifu Pharmaceutical Limited Liability Company? This is my company